Why do we need IgM memory B cells?

Immunology Letters

Volumn 152, Issue 2, 2013, Pages 114-120

  Capolunghi, Federica ^a   Rosado, M Manuela ^a   Sinibaldi, Matilde ^a   Aranburu, Alaitz ^a   Carsetti, Rita ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

CpG; IgM memory B cells; Memory B cells; Natural antibodies; Spleen; TLR9

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9; TLR9 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; BACTERIAL INFECTION; COMMON VARIABLE IMMUNODEFICIENCY; EVOLUTION; FISH; GENETIC CONSERVATION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL MEMORY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MEMORY CELL; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; ROTAVIRUS; SIGNAL TRANSDUCTION; SPLEEN; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; IMMUNOLOGY; MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MICE; SPLEEN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 84879143363     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.04.007     Document Type: Review

References (105)

1. Lanzavecchia A., Sallusto F. Human B cell memory. Curr Opin Immunol 2009, 21:298-304.
2. McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev 2011, 12:24-34.
3. Allen C.D., Okada T., Cyster J.G. Germinal-center organization and cellular dynamics. Immunity 2007, 27:190-202.
4. Amanna I.J., Slifka M.K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 2010, 236:125-138.
5. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
6. Kunkel E.J., Butcher E.C. Plasma-cell homing. Nat Rev 2003, 3:822-829.
7. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
8. Tarlinton D., Radbruch A., Hiepe F., Dorner T. Plasma cell differentiation and survival. Curr Opin Immunol 2008, 20:162-169.
9. Manz R.A., Lohning M., Cassese G., Thiel A., Radbruch A. Survival of long-lived plasma cells is independent of antigen. Int Immunol 1998, 10:1703-1711.
10. Yoshida T., Mei H., Dorner T., Hiepe F., Radbruch A., Fillatreau S., et al. Memory B and memory plasma cells. Immunol Rev 2010, 237:117-139.
11. Manz R.A., Hauser A.E., Hiepe F., Radbruch A. Maintenance of serum antibody levels. Ann Rev Immunol 2005, 23:367-386.
12. Morteau O., Gerard C., Lu B., Ghiran S., Rits M., Fujiwara Y., et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol 2008, 181:6309-6315.
13. Wilson E., Butcher E.C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004, 200:805-809.
14. Boumahrou N., Chevaleyre C., Berri M., Martin P., Bellier S., Salmon H. An increase in milk IgA correlates with both pIgR expression and IgA plasma cell accumulation in the lactating mammary gland of PRM/Alf mice. J Reprod Immunol 2012, 96:25-33.
15. Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 2003, 21:3382-3388.
16. Brandtzaeg P., Farstad I.N., Johansen F.E., Morton H.C., Norderhaug I.N., Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev 1999, 171:45-87.
17. Zinkernagel R.M. On natural and artificial vaccinations. Ann Rev Immunol 2003, 21:515-546.
18. Klein U., Kuppers R., Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997, 89:1288-1298.
19. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Ann Rev Immunol 2009, 27:267-285.
20. Weller S., Faili A., Garcia C., Braun M.C., Le Deist F.F., de Saint Basile G.G., et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A 2001, 98:1166-1170.
21. Weller S., Mamani-Matsuda M., Picard C., Cordier C., Lecoeuche D., Gauthier F., et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 2008, 205:1331-1342.
22. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
23. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
24. Capolunghi F., Cascioli S., Giorda E., Rosado M.M., Plebani A., Auriti C., et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008, 180:800-808.
25. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev 2004, 4:499-511.
26. Dunne A., Ejdeback M., Ludidi P.L., O'Neill L.A., Gay N.J. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J Biol Chem 2003, 278:41443-41451.
27. Weller S., Bonnet M., Delagreverie H., Israel L., Chrabieh M., Marodi L., et al. IgM+ IgD+ CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood 2012, 120:4992-5001.
28. Capolunghi F., Rosado M.M., Cascioli S., Girolami E., Bordasco S., Vivarelli M., et al. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. Rheumatology 2010, 49:2281-2289.
29. Loiarro M., Sette C., Gallo G., Ciacci A., Fanto N., Mastroianni D., et al. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B. J Biol Chem 2005, 280:15809-15814.
30. Lanzavecchia A., Bernasconi N., Traggiai E., Ruprecht C.R., Corti D., Sallusto F. Understanding and making use of human memory B cells. Immunol Rev 2006, 211:303-309.
31. Couch R.B., Atmar R.L., Franco L.M., Quarles J.M., Nino D., Wells J.M., et al. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin Infect Dis 2012, 54:311-317.
32. Skountzou I., Koutsonanos D.G., Kim J.H., Powers R., Satyabhama L., Masseoud F., et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010, 185:1642-1649.
33. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536.
34. Throsby M., van den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 2008, 3:e3942.
35. Benson M.J., Elgueta R., Schpero W., Molloy M., Zhang W., Usherwood E., et al. Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 2009, 206:2013-2025.
36. Dogan I., Bertocci B., Vilmont V., Delbos F., Megret J., Storck S., et al. Multiple layers of B cell memory with different effector functions. Nat Immunol 2009, 10:1292-1299.
37. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999, 274:18470-18476.
38. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
39. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 2005, 22:367-377.
40. Barreto V.M., Magor B.G. Activation-induced cytidine deaminase structure and functions: a species comparative view. Dev Comp Immunol 2010, 35:991-1007.
41. Kosco-Vilbois M.H. Are follicular dendritic cells really good for nothing?. Nat Rev 2003, 3:764-769.
42. Tangye S.G., Good K.L. Human IgM+ CD27+ B cells: memory B cells or "memory" B cells?. J Immunol 2007, 179:13-19.
43. Kuraoka M., Holl T.M., Liao D., Womble M., Cain D.W., Reynolds A.E., et al. Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci U S A 2011, 108:11560-11565.
44. Meyers G., Ng Y.S., Bannock J.M., Lavoie A., Walter J.E., Notarangelo L.D., et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A 2011, 108:11554-11559.
45. Cattoretti G., Buttner M., Shaknovich R., Kremmer E., Alobeid B., Niedobitek G. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006, 107:3967-3975.
46. Marusawa H., Chiba T. Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr Opin Immunol 2010, 22:442-447.
47. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007, 13:470-476.
48. Bajoghli B., Guo P., Aghaallaei N., Hirano M., Strohmeier C., McCurley N., et al. A thymus candidate in lampreys. Nature 2011, 470:90-94.
49. Guo P., Hirano M., Herrin B.R., Li J., Yu C., Sadlonova A., et al. Dual nature of the adaptive immune system in lampreys. Nature 2009, 459:796-801.
50. Barreto V.M., Pan-Hammarstrom Q., Zhao Y., Hammarstrom L., Misulovin Z., Nussenzweig M.C. AID from bony fish catalyzes class switch recombination. J Exp Med 2005, 202:733-738.
51. Wakae K., Magor B.G., Saunders H., Nagaoka H., Kawamura A., Kinoshita K., et al. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID. Int Immunol 2006, 18:41-47.
52. Durandy A. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation. Eur J Immunol 2003, 33:2069-2073.
53. Seifert M., Kuppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 2009, 206:2659-2669.
54. Pape K.A., Taylor J.J., Maul R.W., Gearhart P.J., Jenkins M.K. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011, 331:1203-1207.
55. Wu Y.C., Kipling D., Leong H.S., Martin V., Ademokun A.A., Dunn-Walters D.K. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 2010, 116:1070-1078.
56. Aranburu A., Ceccarelli S., Giorda E., Lasorella R., Ballatore G., Carsetti R. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J Immunol 2010, 185:7293-7301.
57. Carsetti R., Rosado M.M., Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004, 197:179-191.
58. Carsetti R. Characterization of B-cell maturation in the peripheral immune system. Methods Mol Biol 2004, 271:25-35.
59. Longo N.S., Lugar P.L., Yavuz S., Zhang W., Krijger P.H., Russ D.E., et al. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood 2009, 113:3706-3715.
60. Moschese V., Orlandi P., Di Matteo G., Chini L., Carsetti R., Di Cesare S., et al. Insight into B cell development and differentiation. Acta Paediatr Suppl 2004, 93:48-51.
61. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003, 197:939-945.
62. Carsetti R., Rosado M.M., Donnanno S., Guazzi V., Soresina A., Meini A., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005, 115:412-417.
63. Snapper C.M. Mechanisms underlying in vivo polysaccharide-specific immunoglobulin responses to intact extracellular bacteria. Ann N Y Acad Sci 2012, 1253:92-101.
64. Bruyn G.A., Zegers B.J., van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis 1992, 14:251-262.
65. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004, 104:3647-3654.
66. Mamani-Matsuda M., Cosma A., Weller S., Faili A., Staib C., Garcon L., et al. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 2008, 111:4653-4659.
67. Di Sabatino A., Carsetti R., Corazza G.R. Post-splenectomy and hyposplenic states. Lancet 2011, 378:86-97.
68. Mebius R.E., Kraal G. Structure and function of the spleen. Nat Rev 2005, 5:606-616.
69. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
70. You Y., Myers R.C., Freeberg L., Foote J., Kearney J.F., Justement L.B., et al. Marginal zone B cells regulate antigen capture by marginal zone macrophages. J Immunol 2011, 186:2172-2181.
71. den Haan J.M., Kraal G. Innate immune functions of macrophage subpopulations in the spleen. J Innate immun 2012, 4:437-445.
72. Cameron P.U., Jones P., Gorniak M., Dunster K., Paul E., Lewin S., et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS ONE 2011, 6:e23164.
73. Cadili A., de Gara C. Complications of splenectomy. Am J Med 2008, 121:371-375.
74. Holdsworth R.J., Irving A.D., Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991, 78:1031-1038.
75. Wardemann H., Boehm T., Dear N., Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 2002, 195:771-780.
76. Rosado M.M., Aranburu A., Capolunghi F., Giorda E., Cascioli S., Cenci F., et al. From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol 2009, 2:351-361.
77. Herbst E.W., Armbruster M., Rump J.A., Buscher H.P., Peter H.H. Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol 1994, 95:215-221.
78. Malamut G., Verkarre V., Suarez F., Viallard J.F., Lascaux A.S., Cosnes J., et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010, 105:2262-2275.
79. Shulzhenko N., Morgun A., Hsiao W., Battle M., Yao M., Gavrilova O., et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011, 17:1585-1593.
80. Busse P.J., Farzan S., Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 2007, 98:1-8. [quiz 8-11, 43].
81. Park J.H., Resnick E.S., Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011, 1246:41-49.
82. Overturf G.D., American Academy of Pediatrics, Committee on Infectious Diseases Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000, 106:367-376.
83. Goldblatt D., Hussain M., Andrews N., Ashton L., Virta C., Melegaro A., et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 2005, 192:387-393.
84. Brown J.S., Hussell T., Gilliland S.M., Holden D.W., Paton J.C., Ehrenstein M.R., et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A 2002, 99:16969-16974.
85. Ram S., Lewis L.A., Rice P.A. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 2010, 23:740-780.
86. Hussain M., Melegaro A., Pebody R.G., George R., Edmunds W.J., Talukdar R., et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 2005, 133:891-898.
87. Kong I., Sato A., Yuki Y., Nochi T., Takahashi H., Sawada S., et al. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by pneumococcus. Infect Immun 2013, 81(5):1625-1634.
88. Sun K., Johansen F.E., Eckmann L., Metzger D.W. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J Immunol 2004, 173:4576-4581.
89. Lycke N., Erlandsson L., Ekman L., Schon K., Leanderson T. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol 1999, 163:913-919.
90. Uren T.K., Johansen F.E., Wijburg O.L., Koentgen F., Brandtzaeg P., Strugnell R.A. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol 2003, 170:2531-2539.
91. Johansen F.E., Kaetzel C.S. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 2011, 4:598-602.
92. Kaetzel C.S. Polymeric Ig receptor: defender of the fort or Trojan horse?. Curr Biol 2011, 11:35-38.
93. Kilian M., Reinholdt J., Lomholt H., Poulsen K., Frandsen E.V. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996, 104:321-338.
94. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000, 192:271-280.
95. Forster I., Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol 1987, 17:521-528.
96. Herzenberg L.A., Kantor A.B., Herzenberg L.A. Layered evolution in the immune system. A model for the ontogeny and development of multiple lymphocyte lineages. Ann N Y Acad Sci 1992, 651:1-9.
97. Kataoka K., Fujihashi K., Sekine S., Fukuiwa T., Kobayashi R., Suzuki H., et al. Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J Immunol 2007, 178:6058-6065.
98. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatrics 2010, 156:S8-S15.
99. Lopatin U., Blutt S.E., Conner M.E., Kelsall B.L. Lymphotoxin alpha-deficient mice clear persistent rotavirus infection after local generation of mucosal IgA. J Virol 2013, 87:524-530.
100. Pichichero M.E., Blatter M.M., Reisinger K.S., Harrison C.J., Johnson C.E., Steinhoff M.C., et al. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination. Pediatr Infect Dis J 2002, 21:854-859.
101. Couloigner V., Levy C., Francois M., Bidet P., Hausdorff W.P., Pascal T., et al. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels. Pediatr Infect Dis J 2012, 31:154-158.
102. Ma C., Ye J., Kaattari S.L. Differential compartmentalization of memory B cells versus plasma cells in salmonid fish. Eur J immunol 2013, 43:360-370.
103. Rombout J.H., Huttenhuis H.B., Picchietti S., Scapigliati G. Phylogeny and ontogeny of fish leucocytes. Fish Shellfish Immunol 2005, 19:441-455.
104. Zhang Y.A., Salinas I., Li J., Parra D., Bjork S., Xu Z., et al. IgT, a primitive immunoglobulin class specialized in mucosal immunity. Nat Immunol 2010, 11:827-835.
105. Du Pasquier L., Robert J., Courtet M., Mussmann R. B-cell development in the amphibian Xenopus. Immunol Rev 2000, 175:201-213.